Last updated: 2026-10-14 13:03:20. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
GE HealthCare Technologies Inc. (GEHC) operates in the X-RAY APPARATUS & TUBES & RELATED IRRADIATION APPARATUS sector and is listed on NASDAQ. The stock is currently priced at $68.53, with a market capitalization of $30.60B and a P/E ratio of 15.65. Over the past 52 weeks, its price has ranged from $58.75 to $89.77. This page covers its latest market performance, valuation, price trends and company information.
$30.60B | |
$68.90 | |
$94.80 | |
$53.50 | |
$68.79 | |
2.60K | |
3.93M | |
15.65 | |
$89.77 | |
$58.75 | |
0.21% | |
-- |
GE HealthCare Technologies Inc. (GEHC) is trading at $68.53 in pre-market trading as of 2026-10-14 13:00:00, down 0.39% ($0.27) from the previous close of $68.79
Pre-market trading shows how investors are pricing GEHC before the regular session opens. The current pre-market price is near the previous close, indicating cautious early trading sentiment.
Over the past seven days, GE HealthCare Technologies Inc. (GEHC) moved from $65.74 to $68.53, representing a gain of 4.24% ($2.79).
The stock traded between $63.32 and $69.36 during the period. The latest price is near the upper end of the 7-day range, indicating moderate upward.
The average daily volume was 3.85 million shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 31.5%
GEHC is currently trading at $68.53, placing it 31.5% of the way from its 52-week low of $58.75 to its 52-week high of $89.77. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (15%), and pharmaceutical diagnostics (14%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 11%, and 17%, respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one-third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).
| Industry | X-RAY APPARATUS & TUBES & RELATED IRRADIATION APPARATUS |
| Employees | 54000 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of GE HealthCare Technologies Inc. (GEHC) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.